Atwood & Palmer’s QuidelOrtho QDEL Stock Holding History

Atwood & Palmer’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2	Closed	-$147	–	428
2023 Q3	$147	Buy	+2	New	+$160	﹤0.01%	400

Other funds holding QDEL

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

Atwood & Palmer's QDEL Position: Q4 2023 in Review

Atwood & Palmer sold out of QuidelOrtho (QDEL) in Q4 2023, closing a stake of 2 shares — an estimated $147 sold.

Atwood & Palmer first reported a position in QDEL in Q3 2023 and held it in 1 quarter. The position peaked at $147 in Q3 2023. 306 funds tracked by Wall St. Rank hold QDEL as of Q4 2023.

Atwood & Palmer reported no remaining QuidelOrtho position as of Q4 2023 after selling out during the quarter.
Atwood & Palmer sold 2 QuidelOrtho shares in Q4 2023, an estimated $147.
Atwood & Palmer first reported a position in QuidelOrtho in Q3 2023 and held it in 1 quarter.
Atwood & Palmer's QuidelOrtho position peaked at $147 in Q3 2023.
306 funds tracked by Wall St. Rank held QuidelOrtho as of Q4 2023.

Based on Atwood & Palmer's 13F filing for Q4 2023, filed 12 Jan 2024.